Please login to the form below

Not currently logged in
Email:
Password:

CCC expands specialist market team

Chandler Chicco Companies has appointed four new staff to Brandtectonics Access, their specialist market access business unit

Chandler Chicco Companies (CCC), an inVentiv Health company, has announced the appointment of four new staff to Brandtectonics Access, their specialist market access business unit. Established in January 2008, Brandtectonics Access now employs 11 full-time staff in London supported by a network of seven specialist consultants.

"We're delighted our specialist market access consultancy continues to grow, providing services from clinical trial enhancement to payer engagement to end-of-lifecycle strategies, focusing on those areas where innovation and superior communication add the greatest value to our clients," says Fiona Hall, European Director of Operations for CCC.

New recruits at Brandtectonic Access

 Dr Emma-Kate Yates joins from Fast4wD Ogilvy where she held the position of account director. With over eight years experience in specialist healthcare communications, including clinical trial recruitment and retention, Emma-Kate will be responsible for delivering Brandtectonics Access patient enrolment services.

Dr Gaëlle Marinoni joins from IHS Global Insight where she held the position of Senior Healthcare and Pharma Analyst. Gaëlle will be responsible for supporting the team to develop and deliver innovative market access strategies and programmes.

In addition, Brandtectonics Access welcomes graduates Lucy Horrell and Cameron Lockwood. Lucy holds a BSc (Hons) in Biology from the University of York and Cameron holds a BSc (Hons) in Molecular Biology from the University of Manchester. 

17th September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics